The trade deficit grew so much in September thanks to Asia imports that the U.S. will import the equivalent of the entire Mexican economy in 2021. A strong dollar is adding to the trade imbalances with Europe, Mexico, China and southeast Asia.
The Senate Judiciary Committee hears from witnesses on how to combat online-sold counterfeit goods from flooding the U.S. They missed one key remedy — de minimis rulemaking needs a closer look.
A report by business intel firm Horizon Advisory shows China’s encroachment on the European steel industry. What might it mean for Section 232 tariffs against European steel?
BlackRock is the subject of an ad campaign that will highlight the country’s largest financial institution’s kowtowing to China. Only recently was the company banned from investing in Chinese military contractors. For years, BlackRock has been a funder of China’s military and its surveillance state.
A recent House Committee hearing on capital markets and China took on the question of sanctions and delisting. Is there more to come?
A Boston Celtics player gets the NBA team in trouble in China. But Enes Kanter is showing companies what is truly at stake if they dare go against a CCP narrative.
A House Foreign Affairs Committee hearing this week on climate change discusses the prevalence of green finance. And a growing distrust over China’s commitments and its solar supply chain, especially in Xinjiang.
A House committee hearing on the impact of the supply crisis on small businesses left out one key solution: import less, make more here.
A senior Chinese official told the U.S. China Business Council that the U.S. and China should partner on EVs and biotech. The private sector can do what it wants. But Washington should not take Beijing up on this offer.
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
